[Expression and clinical significance of runt-related transcription factor 3 in children with bronchiolitis]

Shuai Men1, Yan-Yan Yu, Yu-Hong Zhang

  • 1Department of Pediatric Asthma, Lianyungang Maternal and Child Health Care Hospital, Lianyungang, Jiangsu 222006, China. wangjunhuayyy@sina.com.

Insights

RUNX3 mRNA levels are lower in children with bronchiolitis, especially those with atopy. This finding may help identify children with bronchiolitis at high risk for asthma.

Area of Science:

  • Pediatric Respiratory Medicine
  • Immunology
  • Molecular Biology

Background:

  • Bronchiolitis is a common respiratory infection in infants.
  • Atopic constitution is a risk factor for developing asthma.
  • RUNX3 plays a role in immune regulation.

Purpose of the Study:

  • To investigate the mRNA levels of runt-related transcription factor 3 (RUNX3) in children with bronchiolitis.
  • To determine the clinical significance of RUNX3 in bronchiolitis, particularly in relation to atopy.
  • To explore the association between RUNX3 expression and key inflammatory markers.

Main Methods:

  • Quantitative real-time PCR was used to measure RUNX3 mRNA in peripheral blood mononuclear cells of 54 children with bronchiolitis and 48 healthy controls.
  • Serum levels of interleukin-4 (IL-4) and interferon gamma (IFN-γ) were measured using ELISA.
  • Participants were categorized based on atopic status.

Main Results:

  • Children with bronchiolitis exhibited significantly lower RUNX3 mRNA levels compared to healthy controls.
  • The atopic bronchiolitis group showed markedly reduced RUNX3 mRNA levels compared to non-atopic and healthy groups.
  • Lower RUNX3 mRNA levels correlated negatively with IL-4 and positively with IFN-γ.

Conclusions:

  • RUNX3 gene expression in peripheral blood mononuclear cells is a potential biomarker in bronchiolitis.
  • RUNX3 measurement may aid in identifying children with bronchiolitis who have an atopic constitution and are at high risk for asthma.
  • The findings suggest a role for RUNX3 in the immunopathogenesis of atopic bronchiolitis.
Abstract